52 -5 (37) 2021 - Odilova G.R. - EARLY MORPHOMETRIC CHANGES IN THE MACULAR ZONE OF THE RETINA IN PATIENTS WITH DIABETES MELLITUS WITHOUT CLINICAL MANIFESTATIONS OF DIABETIC RETINOPATHY

EARLY MORPHOMETRIC CHANGES IN THE MACULAR ZONE OF THE RETINA IN PATIENTS WITH DIABETES MELLITUS WITHOUT CLINICAL MANIFESTATIONS OF DIABETIC RETINOPATHY

Odilova G.R. Bukhara State Medical Institute

Resume

A clinical and morphometric study thickness and volume of the retina, the state of the retinal section in type 2 diabetes mellitus was carried out in 50 patients without diabetic retinopathy. The criteria for inclusion in the study were 1. MCVA> 0.8 with refractive deviations no more than ± 3.0 diopters. No history of ophthalmic operations, retinal and optic nerve pathology (AMD, epiretinal membrane, glaucoma, etc.). The macular zone (5 mm) was scanned according to the E MM5 protocol. This tomograph allows you to segment and calculate the thickness of the inner (ganglion cell complex) and outer retina (layers between the pigment epithelium and the inner plexiform layer). We assessed the total thickness, the thickness of the inner and outer layers of the retina in the foveal (corresponding to a diameter of 1 mm from the fovea), parafoveal (3 mm from the foveola) and peripheral (5 mm from the foveola) zones.

Key words: diabetes mellitus, OCT, fovea, diabetic retinopathy.

First page

175

Last page

179

For citation:Odilova G.R. EARLY MORPHOMETRIC CHANGES IN THE MACULAR ZONE OF THE RETINA IN PATIENTS WITH DIABETES MELLITUS WITHOUT CLINICAL MANIFESTATIONS OF DIABETIC RETINOPATHY//New Day in Medicine 5(37)2021 175-179 https://cutt.ly/6YdUQm1

LIST OF REFERENCES:

1. Astakhov Yu.S., Shadrichev F.Ye., Lisochkina A.B. Diabeticheskaya retinopatiya / Klinicheskiye rekomendatsii «Oftal'mologiya 2006» pod redaktsiyey L.K.Moshetovoy, A.P.Nesterova, Ye.A.Yegorova // Izdatel'skaya gruppa «GOETAR-Media». – M., 2006. – S. 139–163.
2. Astakhov Yu.S., Shadrichev F.Ye.,Lisochkina A.B. Diabeticheskayaretinopatiya (taktika vedeniya patsiyentov) //Klinicheskaya oftal'mologiya. – /M., 2004.T. 5. № 2.– S. 85–92.3. American Diabetes Association. Screeningfor diabetic retinopathy //Diabetes Care. –1997.–V. 20.– P. 28–30.
3. Diabetes Control and Complication TrialResearch Group. The relationship ofglycemic exposure (HbA1с) to the risk ofdevelopment and progression in the DiabetesControl and Complication Trial //Diabetes. –1995.– V. 44.– P. 968–983.
4. Diabetic Retinopathy Study ResearchGroup. Report No 8.Photocoagulationtreatment of proliferative diabeticretinopathy. Clinical application of diabetic retinopathy study (DRS) findings //Ophthalmology. – 1981. – V. 88. – P. 583–600.
5. Diabetic Retinopathy Vitrectomy Study Research Group: Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision: results of a randomized trial. DRVS Report No 3 //Ophthalmology.–1988. – V. 95. – P. 1307–1320.
6. Early Treatment Diabetic Retinopathy StudyResearch Group. Early photocoagulation for diabetic retinopathy. ETDRS report No 9 //Ophthalmology. – 1991. – V.98. – P. 766– 785.
7. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report No 12 //иOphthalmology. – 1991.– V. 98. – P. 823–и33.
8. Javitt J.C., Canner J.K., Sommer A. Costиeffectiveness of current approaches to the control of retinopathy in type 1 diabetics //Ophthalmology. – 1989. – V.96.– P. 255– 264.
9. Kahn H.A., Hiller R. Blindness caused by diabetic retinopathy // Am J Ophthalmol.–1974. – V. 78. – P. 58–67.

   file

   download